Expression Table for this CRE
| CNhs14082 | globus pallidus, newborn, donor10223 | 4.6 |
| CNhs14573 | Myoblast differentiation to myotubes, day06, control donor2 | 1.8 |
| SRX18306677 | TDP2 null mutant, empty vector overexpression_ treated with Estrogen_3h, rep3 | 1.1 |
| SRX9760347 | skeletal muscle_6_h_after_exercise (Individual 6) | 1.0 |
| CNhs11835 | osteoclastoma cell line:Hs 706.T | 1.0 |
| CNhs12324 | putamen, adult, donor10196 | 0.9 |
| CNhs13833 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1 | 0.9 |
| CNhs12698 | K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2 | 0.9 |
| CNhs14499 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3 | 0.6 |
| SRX18306680 | TDP2 null mutant, empty vector overexpression_ treated with Estrogen_6h, rep3 | 0.5 |
| CNhs12655 | MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2 | 0.5 |
| CNhs12652 | MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2 | 0.5 |
| CNhs13581 | Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45) | 0.5 |
| CNhs12653 | MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2 | 0.5 |
| CNhs14060 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2 | 0.4 |
| CNhs12075 | Hepatic Sinusoidal Endothelial Cells, donor1 | 0.4 |
| CNhs13434 | mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1 | 0.4 |
| CNhs12659 | MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2 | 0.4 |
| CNhs12405 | Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction) | 0.4 |
| CNhs12663 | MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 0.4 |
| SRX18306681 | TDP2 null mutant_treated with Estrogen_0h, rep1 | 0.4 |
| SRX18306679 | TDP2 null mutant, empty vector overexpression_ treated with Estrogen_6h, rep2 | 0.4 |
| CNhs12642 | Bronchial Epithelial Cell, donor7 | 0.4 |
| SRX18306678 | TDP2 null mutant, empty vector overexpression_ treated with Estrogen_6h, rep1 | 0.4 |
| CNhs11371 | Adipocyte - subcutaneous, donor2 | 0.3 |
| CNhs13851 | Myoblast differentiation to myotubes, day04, control donor1 | 0.3 |
| CNhs12666 | MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2 | 0.3 |
| CNhs12017 | Adipocyte - subcutaneous, donor3 | 0.3 |
| CNhs11680 | lung, fetal, donor1 | 0.3 |
| CNhs13387 | Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2) | 0.3 |
| CNhs11723 | leiomyoma cell line:15242A | 0.3 |
| CNhs12473 | K562 erythroblastic leukemia response to hemin, day03, biol_rep1 | 0.3 |
| CNhs14073 | occipital cortex, newborn, donor10223 | 0.3 |
| CNhs11885 | small cell cervical cancer cell line:HCSC-1 | 0.3 |
| CNhs12664 | MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 0.3 |
| CNhs12660 | MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 0.3 |
| CNhs13598 | mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2 | 0.3 |
| CNhs12925 | Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1) | 0.2 |
| CNhs11912 | Fibroblast - skin spinal muscular atrophy, donor3 | 0.2 |
| CNhs12064 | Anulus Pulposus Cell, donor2 | 0.2 |
| SRX12709116 | Heart (Sample 107); the left and right atrial free wall, right and left ventricular base, and inferior and superior sinoatrial node | 0.2 |
| CNhs12597 | Smooth Muscle Cells - Umbilical Vein, donor1 | 0.2 |
| SRX18306684 | wild type_treated with ATM inhibitor and ethanol_2 h, rep1 | 0.2 |
| CNhs12684 | K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2 | 0.2 |
| CNhs12432 | MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1 | 0.2 |
| CNhs11722 | leiomyoma cell line:10964C | 0.2 |
| CNhs11717 | oral squamous cell carcinoma cell line:HSC-3 | 0.2 |
| SRX18306676 | TDP2 null mutant, empty vector overexpression_ treated with Estrogen_3h, rep2 | 0.2 |
| CNhs11714 | chronic lymphocytic leukemia (T-CLL) cell line:SKW-3 | 0.2 |
| CNhs11718 | mesenchymal stem cell line:Hu5/E18 | 0.2 |